Latest filing published 20 Apr 2012 for SERACARE LIFE SCIENCES INC.
No signal scores available.
All filings by Brian McLain on record concern Seracare Life Sciences Inc. The record holds 6 filings, for trades running from 8 December 2010 to 20 April 2012.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 20 April 2012 came the latest disclosure, a transaction in Seracare Life Sciences Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations